Regenerative treatment with umbilical cord mesenchymal stem cells from Wharton’s jelly in chronic ulcer caused by dermolipectomy

7Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Procedures to remove adiposities and skin, such as dermolipectomy, can develop wounds that are difficult to heal by conventional therapies. Mesenchymal stem cells are indicated as potential candidates for regenerative therapy in wounds, due to their multipotentiality, low immunogenicity, modulating capacity of inflammation and tissue modeling processes. Case report: Patient with dehiscent chronic ulcer secondary to dermolipectomy, who received cutaneous treatment with mesenchymal stem cells. The therapy induced scar formation and neovascularization, as well as the decrease of infiltrated leukocytes and proinflammatory cytokines. Mesenchymal cells are proposed as an interesting alternative for the treatment of postoperative lesions.

Cite

CITATION STYLE

APA

Mejía-Barradas, C. M., Cázares-Montañez, J. E., Guerra-Márquez, Á., Hernández-Chávez, V. G., Cáceres-Cortés, J. R., & Gutiérrez-Iglesias, G. (2019). Regenerative treatment with umbilical cord mesenchymal stem cells from Wharton’s jelly in chronic ulcer caused by dermolipectomy. Cirugia y Cirujanos (English Edition), 87, 8–16. https://doi.org/10.24875/CIRU.18000515

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free